• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前嗜铬粒蛋白A表达在前列腺癌根治术后的预后作用

The prognostic role of preoperative chromogranin A expression in prostate cancer after radical prostatectomy.

作者信息

Masieri Lorenzo, Lanciotti Michele, Gontero Paolo, Marchioro Giansilvio, Mantella Annalisa, Zaramella Stefano, Minervini Andrea, Lapini Alberto, Carini Marco, Serni Sergio

机构信息

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.

出版信息

Arch Ital Urol Androl. 2012 Mar;84(1):17-21.

PMID:22649955
Abstract

PURPOSES

The aim was to analyze the prognostic role of preoperative chromogranin A CgA) as a marker of poor prognosis and recurrence after radical prostatectomy (RP) and to find a correlation with the other well known prognostic variables.

MATERIALS AND METHODS

This study comprises 306 patients with prostate cancer prospectively recruited who underwent RP from between 2000 and 2005. A blood sample for the determination of serum preoperative CgA value was obtained in all cases. Spearman correlation test was used to compare CgA to other variables, Kruskal-Wallis test to analyze CgA differences among > or = 3 groups (PSA, GS, Stage), Mann-Whitney test for 2 grouping variables. Survival analysis was estimated by Kaplan-Meier method, log-rank test to estimate differences among the analyzed variables.

RESULTS

Median CgA level was 68 ng/ml. Correlation between age and CgA levels was positive and statistically significant (p < 0.001). Patient were divided in 2 groups based on median age.The difference was statistically significant (p = 0.002). Comparison of CgA among patients grouped according to other variables and patient stratified on normal (123 ng/ml) and cut-off value (68 ng/ml) of CgA did not achieve significant risk stratification.

CONCLUSION

Studies on a possible prognostic role of CgA have provided conflicting results. In our series we found a significant positive correlation between CgA and age, but no significant statistical correlation with other available variables analyzed.

摘要

目的

旨在分析术前嗜铬粒蛋白A(CgA)作为前列腺癌根治术(RP)后预后不良及复发标志物的预后作用,并找出其与其他已知预后变量的相关性。

材料与方法

本研究前瞻性纳入了2000年至2005年间接受RP的306例前列腺癌患者。所有病例均采集血样以测定术前血清CgA值。采用Spearman相关检验比较CgA与其他变量,采用Kruskal-Wallis检验分析CgA在≥3组(PSA、GS、分期)之间的差异,采用Mann-Whitney检验分析两个分组变量。采用Kaplan-Meier法进行生存分析,采用对数秩检验估计分析变量之间的差异。

结果

CgA水平中位数为68 ng/ml。年龄与CgA水平呈正相关且具有统计学意义(p<0.001)。根据年龄中位数将患者分为两组,差异具有统计学意义(p = 0.002)。根据其他变量分组的患者以及根据CgA正常(123 ng/ml)和临界值(68 ng/ml)分层的患者中CgA的比较未实现显著的风险分层。

结论

关于CgA可能的预后作用的研究结果相互矛盾。在我们的系列研究中,我们发现CgA与年龄之间存在显著正相关,但与分析的其他可用变量无显著统计学相关性。

相似文献

1
The prognostic role of preoperative chromogranin A expression in prostate cancer after radical prostatectomy.术前嗜铬粒蛋白A表达在前列腺癌根治术后的预后作用
Arch Ital Urol Androl. 2012 Mar;84(1):17-21.
2
Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.嗜铬粒蛋白A与接受根治性前列腺切除术的前列腺腺癌患者的生化无进展生存期
Endocr Relat Cancer. 2007 Sep;14(3):625-32. doi: 10.1677/ERC-07-0089.
3
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival.血清嗜铬粒蛋白A作为预测前列腺癌特异性生存的补充标志物。
Pathol Oncol Res. 2017 Jul;23(3):643-650. doi: 10.1007/s12253-016-0171-5. Epub 2016 Dec 23.
4
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery.预测手术后生化进展的前列腺癌患者对间歇性雄激素剥夺治疗(IAD)的反应。
Urol Oncol. 2013 Jul;31(5):607-14. doi: 10.1016/j.urolonc.2011.05.005. Epub 2011 Jun 12.
5
Implications of circulating chromogranin A in prostate cancer.循环嗜铬粒蛋白A在前列腺癌中的意义。
Scand J Urol Nephrol. 2007;41(4):297-301. doi: 10.1080/00365590701303934.
6
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A.接受根治性前列腺切除术的前列腺腺癌患者的临床分期不足:血清嗜铬粒蛋白A的预测价值
Prostate. 2004 Mar 1;58(4):421-8. doi: 10.1002/pros.10347.
7
Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort.嗜铬粒蛋白A的血清水平不能预测高级别、低分化前列腺癌:来自意大利活检队列的结果。
Urol Oncol. 2014 Feb;32(2):80-4. doi: 10.1016/j.urolonc.2012.07.012. Epub 2012 Nov 13.
8
Distribution of high chromogranin A serum levels in patients with nonmetastatic and metastatic prostate adenocarcinoma.非转移性和转移性前列腺腺癌患者血清嗜铬粒蛋白A水平的分布情况
Urol Int. 2009;82(2):147-51. doi: 10.1159/000200789. Epub 2009 Mar 19.
9
Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.增殖活性和神经内分泌分化对预测前列腺癌根治术后治疗失败的预后意义。
Scand J Urol Nephrol. 2007;41(5):375-81. doi: 10.1080/00365590701224445. Epub 2007 Jul 27.
10
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide.嗜铬粒蛋白A是接受恩杂鲁胺治疗的前列腺癌患者的一种潜在预后标志物。
Prostate. 2014 Dec;74(16):1691-6. doi: 10.1002/pros.22890. Epub 2014 Sep 27.

引用本文的文献

1
Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis.循环嗜铬粒蛋白A在前列腺癌中的预后价值:一项系统评价和荟萃分析。
Front Oncol. 2025 Feb 5;15:1521558. doi: 10.3389/fonc.2025.1521558. eCollection 2025.
2
Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.在原发性前列腺癌中对降钙素-降钙素受体轴进行分析:临床意义和分子相关性。
Oncol Rep. 2013 Sep;30(3):1265-74. doi: 10.3892/or.2013.2583. Epub 2013 Jul 2.